Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Non-Drug Cancer Trials

Oklahoma

Non-drug cancer trials in Oklahoma

16 non-drug cancer studies are recruiting participants at sites in 3 cities across Oklahoma as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 338-7068
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Oklahoma city with a recruiting study

By research area: Breast Cancer (6), Prostate Cancer (4), Lung Cancer (2), Lymphoma (2), Melanoma (2).

Oklahoma City (14), Tulsa (2), Lindsay (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Oklahoma

Basic details from each study's public record (the 12 most recently updated of 16). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Oklahoma City
    Registry record
    NCT06995898 · updated
  2. S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Recruiting in
    Oklahoma City
    Registry record
    NCT03723928 · updated
  3. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Oklahoma City
    Registry record
    NCT06748222 · updated
  4. Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

    • Early Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    University of Oklahoma
    Recruiting in
    Oklahoma City · Tulsa
    Registry record
    NCT05921253 · updated
  5. Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

    • Phase 2
    • Ages 50 and older
    • Female participants
    Sponsor
    Proton Collaborative Group
    Recruiting in
    Oklahoma City
    Registry record
    NCT01766297 · updated
  6. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Oklahoma City
    Registry record
    NCT06500481 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Oklahoma on ClinicalTrials.gov.

Lung cancer: recently updated in Oklahoma

  1. Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

    • Phase 3
    • Up to age 50
    • All sexes
    Sponsor
    Children's Oncology Group
    Recruiting in
    Oklahoma City
    Registry record
    NCT05235165 · updated
  2. Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Canadian Cancer Trials Group
    Recruiting in
    Oklahoma City
    Registry record
    NCT06686771 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Oklahoma on ClinicalTrials.gov.

Prostate cancer: recently updated in Oklahoma

  1. Sacral Neuromodulation for Male Overactive Bladder (MOAB)

    • No phase
    • Ages 18 and older
    • Male participants
    Sponsor
    Axonics, Inc.
    Recruiting in
    Tulsa
    Registry record
    NCT06511141 · updated
  2. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    NRG Oncology
    Recruiting in
    Oklahoma City
    Registry record
    NCT05946213 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Oklahoma on ClinicalTrials.gov.

Melanoma: recently updated in Oklahoma

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Oklahoma City
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Oklahoma on ClinicalTrials.gov.

Ask about studies in Oklahoma

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test something other than a medication, biologic or supplement, such as a device, a procedure or a behavioral program, as each study is coded in the registry.

Non-Drug Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 338-7068

or send a short form

How should we reach you?

Call